无ESAT-6干扰素释放试验与QuantiFERON-TB Gold In-tube诊断准确性比较
该研究旨在评估新型无ESAT-6干扰素释放试验(IGRA)的诊断性能,并与QuantiFERON-TB Gold In-tube(QFT)比较。研究在具有不同结核分枝杆菌暴露水平和结核病的参与者中确定无ESAT-6 IGRA的cutoff值,并在独立队列中比较其与QFT的性能。结果显示无ESAT-6 IGRA与QFT高度相关,阳性率相当,一致性为91%,诊断准确性可比。
要点
- 无ESAT-6 IGRA的cutoff值为0.61 IU/mL。
- 与QFT相比,阳性率分别为43.5%和41.5%,一致性91%。
- 该检测适用于评估含ESAT-6疫苗试验中的感染状态。
核心结论
- 新型无ESAT-6 IGRA的诊断准确性可与QFT相比,适用于评估预防结核分枝杆菌感染的候选疫苗的临床试验。
研究设计与样本
- 研究纳入不同结核分枝杆菌暴露水平和结核病的参与者,确定无ESAT-6 IGRA的cutoff值。
- 在独立队列中比较无ESAT-6 IGRA与标准QFT的性能,并对抗原包被采血管进行技术鉴定。
主要发现
- 在QFT阳性和阴性的南非青少年中评估了无ESAT-6 IGRA的抗原识别。
- 基于未暴露对照和微生物学确诊肺结核患者的ROC分析,确定cutoff值为0.61 IU/mL。
- 在健康青少年独立队列中,QFT和无ESAT-6 IGRA释放的IFN-γ水平高度相关(P < .0001, r = 0.83)。
- 两种检测的阳性率分别为41.5%和43.5%,一致性为91%(kappa = 0.82; 95% CI, 0.74-0.90; McNemar检验P = .48)。
- 无ESAT-6 IGRA采血管的批间变异性、精密度和稳定性均可接受。
关键数值与推荐
- 无ESAT-6 IGRA的cutoff值为0.61 IU/mL。
- 与QFT相比,阳性率41.5% vs 43.5%,一致性91%,kappa=0.82(95%CI 0.74-0.90),McNemar P=.48。
临床怎么用
- 在含ESAT-6的结核疫苗临床试验中,可使用无ESAT-6 IGRA区分疫苗诱导的免疫反应与自然感染。
- 无ESAT-6 IGRA可作为QFT的替代方法用于检测结核分枝杆菌感染。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early secretory antigenic target-6 (ESAT-6) is an immunodominant Mycobacterium tuberculosis (M.tb) antigen included in novel vaccines against tuberculosis (TB) and in interferon-gamma (IFN-γ) release assays (IGRAs). Therefore, the availability of an ESAT-6-free IGRA is essential to determine M.tb infection status following vaccination with ESAT-6-containing vaccines. We aimed to qualify a recently developed ESAT-6-free IGRA and to assess its diagnostic performance in comparison to QuantiFERON-TB Gold In-tube (QFT). METHODS: Participants with different levels of M.tb exposure and TB disease were enrolled to determine the ESAT-6-free IGRA cutoff, test assay performance in independent cohorts compared to standard QFT, and perform a technical qualification of antigen-coated blood collection tubes. RESULTS: ESAT-6-free IGRA antigen recognition was evaluated in QFT-positive and QFT-negative South African adolescents. The ESAT-6-free IGRA cutoff was established at 0.61 IU/mL, based on receiver operating characteristic analysis in M.tb-unexposed controls and microbiologically confirmed pulmonary TB patients. In an independent cohort of healthy adolescents, levels of IFN-γ released in QFT and ESAT-6-free IGRA were highly correlated (P < .0001, r = 0.83) and yielded comparable positivity rates, 41.5% and 43.5%, respectively, with 91% concordance between the tests (kappa = 0.82; 95% confidence interval, 0.74-0.90; McNemar test P = .48). ESAT-6-free IGRA blood collection tubes had acceptable lot-to-lot variability, precision, and stability. CONCLUSIONS: The novel ESAT-6-free IGRA had diagnostic accuracy comparable to QFT and is suitable for use in clinical trials to assess efficacy of candidate TB vaccines to prevent established M.tb infection.
引用
- Nemes E, Abrahams D, Scriba TJ, et al. Diagnostic Accuracy of Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay Compared to QuantiFERON-TB Gold In-tube. Clin Infect Dis. 2019. PMID: 30668657. doi:10.1093/cid/ciz034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。